Insider: Or Yat Sun Chief Scientific Officer - ENANTA PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 371,392 | 0 | 371,392 |
| Value | $4,880,090.88 | $0.00 | $4,880,090.88 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 12/05/2025 | DDS | 2,390 | Direct | COM | $14.23 | $34,009.70 | 371,392 |
| 12/05/2023 | DDS | 2,412 | Direct | COM | $9.63 | $23,227.56 | 370,695 |
| 03/15/2023 | DDS | 269 | Direct | COM | $43.92 | $11,814.48 | 388,358 |
| 03/15/2023 | DDS | 13,656 | Direct | COM | $44.46 | $607,145.76 | 374,702 |
| 03/01/2019 | DDS | 5,910 | Direct | COM | $103.32 | $610,627.70 | 304,763 |
| 03/01/2019 | DDS | 4,090 | Direct | COM | $103.84 | $424,692.51 | 300,673 |
| 02/12/2019 | DDS | 6,297 | Direct | COM | $90.07 | $567,173.31 | 301,916 |
| 02/11/2019 | DDS | 5,835 | Direct | COM | $88.66 | $517,321.18 | 330,062 |
| 02/11/2019 | DDS | 18,971 | Direct | COM | $89.50 | $1,697,877.94 | 311,091 |
| 02/11/2019 | DDS | 171 | Direct | COM | $91.24 | $15,601.70 | 308,213 |
| 02/11/2019 | DDS | 2,707 | Direct | COM | $90.11 | $243,936.16 | 308,384 |
| 01/04/2017 | DDS | 13,921 | Direct | COM | $35.09 | $488,504.60 | 301,876 |
| 11/29/2016 | DDS | 13,921 | Direct | COM | $31.44 | $437,609.42 | 315,797 |
| 08/10/2015 | DDS | 1,600 | Direct | COM | $43.35 | $69,367.04 | 208,231 |
| 08/10/2015 | DDS | 2,150 | Direct | COM | $42.57 | $91,516.47 | 209,831 |
| 07/13/2015 | DDS | 630 | Direct | COM | $46.56 | $29,333.81 | 211,981 |
| 07/13/2015 | DDS | 3,120 | Direct | COM | $46.24 | $144,260.69 | 212,611 |
| 06/11/2015 | DDS | 3,750 | Direct | COM | $42.47 | $159,264.75 | 215,731 |
| 06/05/2015 | DDS | 10,750 | Direct | COM | $42.02 | $451,662.33 | 219,481 |
| 05/11/2015 | DDS | 8,000 | Direct | COM | $36.13 | $289,044.80 | 230,231 |
| 08/13/2014 | DDS | 100 | Direct | COM | $40.04 | $4,004.00 | 180,227 |
| 08/13/2014 | DDS | 4,900 | Direct | COM | $39.48 | $193,437.30 | 180,327 |
| 07/01/2014 | DDS | 4,700 | Direct | COM | $42.20 | $198,324.96 | 174,378 |
| 07/01/2014 | DDS | 300 | Direct | COM | $42.98 | $12,893.01 | 174,078 |
| 06/02/2014 | DDS | 1,201 | Direct | COM | $38.14 | $45,800.74 | 179,078 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research